Treatment for Aerobic Vaginitis by Using Bofukang Vaginal Suppository
NCT ID: NCT04574089
Last Updated: 2025-06-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE3
50 participants
INTERVENTIONAL
2020-05-01
2026-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Honghe Fujie Lotion for the Treatment of Bacterial Vaginosis
NCT03446443
Study of Lactobacillus in Adjuvant Treatment of RVVC
NCT04699240
Evaluation of Gynecological Acceptability of a Health Care Product
NCT04247022
Safety and Efficacy Study to Treat Bacterial Vaginosis
NCT01621399
A Pilot Study to Evaluate the Efficacy and Safety of Lactobacillus Species Suppositories on Vaginal Health and pH
NCT05060029
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Group 1: Baofukang Suppository (1.74g), for vaginal use, 2 capsules per night for 7 days.
Group 2: Baofukang Suppository (1.74g), for vaginal use, 2 capsules per night for 14 days.
The efficacy and safety will be evaluated 7\~14 days after treatment and 35\~42 days after treatment.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Baofukang Suppository 7 days
Baofukang Suppository (1.74g), for vaginal external use, 2 capsules per night for 7 days
Experimental: Baofukang Suppository 7 days
Experimental: Baofukang Suppository 7 days
Baofukang Suppository 14 days
Baofukang Suppository (1.74g), for vaginal external use, 2 capsules per night for 14days
Experimental: Baofukang Suppository 14 days
Experimental: Baofukang Suppository 14 days
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Experimental: Baofukang Suppository 7 days
Experimental: Baofukang Suppository 7 days
Experimental: Baofukang Suppository 14 days
Experimental: Baofukang Suppository 14 days
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Vaginal dischareg ;
2. pH \> 4.5;
3. Donders score≥3;
Exclusion Criteria
2. Patients received systemic or vaginal antifungal or antibiotic treatment within two weeks before admission.
3. Pregnancy, lactation and intentional pregnancy;
4. Women with liver and kidney dysfunction, low immune function, diabetes, psychosis or other serious diseases;
5. Allergic constitution and patients allergic to drug ingredients in this study;
6. Those with poor compliance.
18 Years
55 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Peking University Shenzhen Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Shangrong Fan
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Shangrong Fan, M.D.
Role: PRINCIPAL_INVESTIGATOR
Dept of Obstetrics and Gynecology,Peking University Shenzhen Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Peking University Shenzhen Hosptal
Shenzhen, Guangdong, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Related Links
Access external resources that provide additional context or updates about the study.
AV diagnosis and outcome Measure
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PUShenzhenH
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.